|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ghose A, Bolina A, Mahajan I, Raza SA,
Clarke M, Pal A, Sanchez E, Rallis KS and Boussios S: Hereditary
ovarian cancer: Towards a cost-effective prevention strategy. Int J
Environ Res Public Health. 19:120572022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lõhmussaar K, Kopper O, Korving J, Begthel
H, Vreuls CPH, van Es JH and Clevers H: Assessing the origin of
high-grade serous ovarian cancer using CRISPR-modification of mouse
organoids. Nat Commun. 11:26602020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maringe C, Walters S, Butler J, Coleman
MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G,
et al: Stage at diagnosis and ovarian cancer survival: Evidence
from the international cancer benchmarking partnership. Gynecol
Oncol. 127:75–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghose A, McCann L, Makker S, Mukherjee U,
Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello
M, et al: Diagnostic biomarkers in ovarian cancer: Advances beyond
CA125 and HE4. Ther Adv Med Oncol. 16:175883592412332252024.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Saani I, Raj N, Sood R, Ansari S,
Mandviwala HA, Sanchez E and Boussios S: Clinical challenges in the
management of malignant ovarian germ cell tumours. Int J Environ
Res Public Health. 20:60892023. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Singh N: WHO classification of tumors of
the ovary. In: Encyclopedia of Pathology. Van Krieken JHJM:
Springer International Publishing; Cham: pp. 1–4. 2022
|
|
8
|
Matulonis UA, Sood AK, Fallowfield L,
Howitt BE, Sehouli J and Karlan BY: Ovarian cancer. Nat Rev Dis
Primers. 2:160612016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pavlidis N, Rassy E, Vermorken JB, Assi T,
Kattan J, Boussios S and Smith-Gagen J: The outcome of patients
with serous papillary peritoneal cancer, fallopian tube cancer, and
epithelial ovarian cancer by treatment eras: 27 years data from the
SEER registry. Cancer Epidemiol. 75:1020452021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kindelberger DW, Lee Y, Miron A, Hirsch
MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW,
Birch C, et al: Intraepithelial carcinoma of the fimbria and pelvic
serous carcinoma: Evidence for a causal relationship. Am J Surg
Pathol. 31:161–169. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shih IM, Wang Y and Wang TL: The origin of
ovarian cancer species and precancerous landscape. Am J Pathol.
191:26–39. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aliyuda F, Moschetta M, Ghose A, Sofia
Rallis K, Sheriff M, Sanchez E, Rassy E and Boussios S: Advances in
ovarian cancer treatment beyond PARP Inhibitors. Curr Cancer Drug
Targets. 23:433–446. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee Y, Miron A, Drapkin R, Nucci MR,
Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, et
al: A candidate precursor to serous carcinoma that originates in
the distal fallopian tube. J Pathol. 211:26–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Colvin EK and Howell VM: Why the dual
origins of high grade serous ovarian cancer matter. Nat Commun.
11:12002020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Greten FR and Grivennikov SI: Inflammation
and cancer: Triggers, mechanisms, and consequences. Immunity.
51:27–41. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Łaniewski P, Ilhan ZE and Herbst-Kralovetz
MM: The microbiome and gynaecological cancer development,
prevention and therapy. Nat Rev Urol. 17:232–250. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chambers LM, Bussies P, Vargas R, Esakov
E, Tewari S, Reizes O and Michener C: The microbiome and
gynecologic cancer: Current evidence and future opportunities. Curr
Oncol Rep. 23:922021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jia D, Nagaoka Y, Katsumata M and Orsulic
S: Inflammation is a key contributor to ovarian cancer cell
seeding. Sci Rep. 8:123942018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sabatini ME and Chiocca S: Human
papillomavirus as a driver of head and neck cancers. Br J Cancer.
122:306–314. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Demarco M, Hyun N, Carter-Pokras O,
Raine-Bennett TR, Cheung L, Chen X, Hammer A, Campos N, Kinney W,
Gage JC, et al: A study of type-specific HPV natural history and
implications for contemporary cervical cancer screening programs.
EClinicalMedicine. 22:1002932020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Scheffner M, Werness BA, Huibregtse JM,
Levine AJ and Howley PM: The E6 oncoprotein encoded by human
papillomavirus types 16 and 18 promotes the degradation of p53.
Cell. 63:1129–1136. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fischer M, Uxa S, Stanko C, Magin TM and
Engeland K: Human papilloma virus E7 oncoprotein abrogates the
p53-p21-DREAM pathway. Sci Rep. 7:26032017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cherif S, Amine A, Thies S, Taube ET,
Braicu EI, Sehouli J and Kaufmann AM: Prevalence of human
papillomavirus detection in ovarian cancer: A meta-analysis. Eur J
Clin Microbiol Infect Dis. 40:1791–1802. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ibragimova MK, Kokorina EV, Tsyganov MM,
Churuksaeva ON and Litviakov NV: Human papillomavirus and ovarian
cancer (review of literature and meta-analysis). Infect Genet Evol.
95:1050862021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grabarek BO, Ossowski P, Czarniecka J,
Ożóg M, Prucnal J, Dziuba I, Ostenda A, Dziobek K, Boroń D, Peszek
W, et al: Detection and genotyping of human papillomavirus
(HPV16/18), Epstein-barr virus (EBV), and human cytomegalovirus
(HCMV) in endometrial endometroid and ovarian cancers. Pathogens.
12:3972023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fatima B, Masud R, Sultana N, Javed A and
Justin S: Detection of human papillomavirus in archival bladder and
ovarian cancer samples. Clin Epidemiology Glob Health.
22:1013392023. View Article : Google Scholar
|
|
27
|
Kumar P, Ranmale S, Tongaonkar H, Mehta S
and Mania-Pramanik J: Human papillomavirus infection: Is it
associated with epithelial ovarian cancer? Indian J Med Microbiol.
39:311–314. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang X, You Q, Yao G, Geng J, Ma R and
Meng H: Evaluation of p16 in epithelial ovarian cancer for a
10-year study in northeast China: Significance of HPV in
correlation with PD-L1 expression. Cancer Manag Res. 12:6747–6753.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shokouh MR, Safaei A, Moattari A and
Sarvari J: Association of human papilloma virus and Epstein-barr
virus with ovarian cancer in Shiraz, southwestern Iran. Iran J
Pathol. 15:292–298. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kisseljova N, Zhordania K, Fedorova M,
Katargin A, Valeeva A, Pajanidi J, Pavlova L, Khvan O and
Vinokurova S: Detection of human papillomavirus prevalence in
ovarian cancer by different test systems. Intervirology.
62:198–204. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Paradowska E, Jabłońska A, Studzińska M,
Wilczyński M and Wilczyński JR: Detection and genotyping of CMV and
HPV in tumors and fallopian tubes from epithelial ovarian cancer
patients. Sci Rep. 9:199352019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hammou RA, Benhessou M, Bouziyane A,
Hassou N, Benhchekroun MN, Bessi H and Ennaji MM: Oncogenic human
papillomavirus involvement in epithelial ovarian carcinoma among
women in Morocco. Bioinformation. 15:55–60. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hassan ZK, Hafez MM, Kamel MM and Zekri
ARN: Human Papillomavirus genotypes and methylation of CADM1, PAX1,
MAL and ADCYAP1 genes in epithelial ovarian cancer patients. Asian
Pac J Cancer Prev. 18:169–176. 2017.PubMed/NCBI
|
|
34
|
Farzaneh F, Nadji SA, Khosravi D, Hosseini
MS, Hashemi Bahremani M, Chehrazi M, Bagheri G, Sigaroodi A and
Haghighatian Z: Lack of HPV in benign and malignant epithelial
ovarian tumors in Iran. Asian Pac J Cancer Prev. 18:1233–1236.
2017.PubMed/NCBI
|
|
35
|
Dadashi M, Eslami G, Faghihloo E,
Pourmohammad A, Hosseini J, Taheripanah R and Arab-Mazar Z:
Detection of human papilloma virus type 16 in epithelial ovarian
tumors samples. Arch Clin Infect Dis. 12:e396662017.
|
|
36
|
Zhang PP, Zhou L, Cao JS, Li YP, Zeng Z,
Sun N, Shen L, Zhu HY, Ruan Y, Zha WT, et al: Possible epithelial
ovarian cancer association with HPV18 or HPV33 infection. Asian Pac
J Cancer Prev. 17:2959–2964. 2016.PubMed/NCBI
|
|
37
|
Ingerslev K, Hogdall E, Skovrider-Ruminski
W, Schnack TH, Karlsen MA, Nedergaard L, Hogdall C and Blaakær J:
High-risk HPV is not associated with epithelial ovarian cancer in a
Caucasian population. Infect Agent Cancer. 11:392016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mahmood FM, Kadhim HS and Mousa Al Khuzaee
LR: Detection of human papillomavirus-16 E6-oncoprotein in
epithelial ovarian tumors samples of Iraqi patients. Jundishapur J
Microbiol. 7:e119452014.PubMed/NCBI
|
|
39
|
Al-Shabanah OA, Hafez MM, Hassan ZK,
Sayed-Ahmed MM, Abozeed WN, Alsheikh A and Al-Rejaie SS:
Methylation of SFRPs and APC genes in ovarian cancer infected with
high risk human papillomavirus. Asian Pac J Cancer Prev.
15:2719–2725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Al-Shabanah OA, Hafez MM, Hassan ZK,
Sayed-Ahmed MM, Abozeed WN, Al-Rejaie SS and Alsheikh AA: Human
papillomavirus genotyping and integration in ovarian cancer Saudi
patients. Virol J. 10:3432013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Malisic E, Jankovic R and Jakovljevic K:
Detection and genotyping of human papillomaviruses and their role
in the development of ovarian carcinomas. Arch Gynecol Obstet.
286:723–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shanmughapriya S, SenthilKumar G,
Vinodhini K, Das BC, Vasanthi N and Natarajaseenivasan K: Viral and
bacterial aetiologies of epithelial ovarian cancer. Eur J Clin
Microbiol Infect Dis. 31:2311–2317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Alavi G, Sharifi N, Sadeghian A, Rezaei A
and Shidaee H: Failure to demonstrate the role of high risk human
papilloma virus in epithelial ovarian cancer. Iran J Pathol.
7:151–156. 2012.
|
|
44
|
Bilyk OO, Pande NT and Buchynska LG:
Analysis of P53, P16INK4A, PRB and Cyclin D1 expression and human
papillomavirus in primary ovarian serous carcinomas. Exp Oncol.
33:150–156. 2011.PubMed/NCBI
|
|
45
|
Idahl A, Lundin E, Elgh F, Jurstrand M,
Møller JK, Marklund I, Lindgren P and Ottander U: Chlamydia
trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, human
papillomavirus, and polyomavirus are not detectable in human tissue
with epithelial ovarian cancer, borderline tumor, or benign
conditions. Am J Obstet Gynecol. 202:71.e1–e6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wentzensen N, du Bois A, Kommoss S,
Pfisterer J, Von Knebel Doeberitz M, Schmidt D and Kommoss F: No
metastatic cervical adenocarcinomas in a series of
p16INK4a-positive mucinous or endometrioid advanced ovarian
carcinomas: An analysis of the AGO ovarian cancer study group. Int
J Gynecol Pathol. 27:18–23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Giordano G, D'Adda T, Gnetti L, Froio E,
Merisio C and Melpignano M: Role of human papillomavirus in the
development of epithelial ovarian neoplasms in Italian women. J
Obstet Gynaecol. 34:210–217. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Atalay F, Taskiran C, Taner MZ, Pak I, Or
M and Tuncer S: Detection of human papillomavirus DNA and
genotyping in patients with epithelial ovarian carcinoma. J Obstet
Gynaecol. 33:823–828. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Konidaris S, Kouskouni EE, Panoskaltsis T,
Kreatsas G, Patsouris ES, Sarivalassis A, Nonni A and Lazaris AC:
Human papillomavirus infection in malignant and benign
gynaecological conditions: A study in Greek women. Health Care
Women Int. 28:182–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Quirk JT, Kupinski JM and DiCioccio RA:
Analysis of ovarian tumors for the presence of human papillomavirus
DNA. J Obstet Gynaecol. 32:202–205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kuscu E, Ozdemir BH, Erkanli S and Haberal
A: HPV and p53 expression in epithelial ovarian carcinoma. Eur J
Gynaecol Oncol. 26:642–645. 2005.PubMed/NCBI
|
|
52
|
Elishaev E, Gilks CB, Miller D, Srodon M,
Kurman RJ and Ronnett BM: Synchronous and metachronous endocervical
and ovarian neoplasms: Evidence supporting interpretation of the
ovarian neoplasms as metastatic endocervical adenocarcinomas
simulating primary ovarian surface epithelial neoplasms. Am J Surg
Pathol. 29:281–294. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Yang HJ, Liu VW, Tsang PC, Yip AM, Ng TY,
Cheung AN and Ngan HY: Comparison of human papillomavirus DNA
levels in gynecological cancers: Implication for cancer
development. Tumor Biol. 24:310–316. 2003. View Article : Google Scholar
|
|
54
|
Wu QJ, Guo M, Lu ZM, Li T, Qiao HZ and Ke
Y: Detection of human papillomavirus-16 in ovarian malignancy. Br J
Cancer. 89:672–675. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li T, Lu ZM, Guo M, Wu QJ, Chen KN, Xing
HP, Mei Q and Ke Y: p53 codon 72 polymorphism (C/G) and the risk of
human papillomavirus-associated carcinomas in China. Cancer.
95:2571–2576. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ip SM, Wong LC, Xu CM, Cheung AN, Tsang PC
and Ngan HY: Detection of human papillomavirus DNA in malignant
lesions from Chinese women with carcinomas of the upper genital
tract. Gynecol Oncol. 87:104–111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Chen TR, Chan PJ, Seraj IM and King A:
Absence of human papillomavirus E6-E7 transforming genes from HPV
16 and 18 in malignant ovarian carcinoma. Gynecol Oncol.
72:180–182. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Anttila M, Syrjänen S, Ji H, Saarikoski S
and Syrjänen K: Failure to demonstrate human papillomavirus DNA in
epithelial ovarian cancer by general primer PCR. Gynecol Oncol.
72:337–341. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zimna K, Poreba E, Kedzia W,
Gozdzicka-Józefiak A and Kezia H: Human papillomavirus (HPV) in
upper genital tract carcinomas of women. Eur J Gynaecol Oncol.
18:415–417. 1997.PubMed/NCBI
|
|
60
|
Anwar K, Nakakuki K, Imai H, Shiraishi T
and Inuzuka M: Infection of human papillomavirus (HPV) and p53
over-expression in human female genital tract carcinoma. J Pak Med
Assoc. 46:220–224. 1996.PubMed/NCBI
|
|
61
|
Trottier AM, Provencher D, Mes-Masson AM,
Vauclair R and Coutlée F: Absence of human papillomavirus sequences
in ovarian pathologies. J Clin Microbiol. 33:1011–1013. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Runnebaum IB, Maier S, Tong XW, Rosenthal
HE, Möbus VJ, Kieback DG and Kreienberg R: Human papillomavirus
integration is not associated with advanced epithelial ovarian
cancer in German patients. Cancer Epidemiol Biomarkers Prev.
4:573–575. 1995.PubMed/NCBI
|
|
63
|
Lai CH, Wang CY, Lin CY and Pao CC:
Detection of human papillomavirus RNA in ovarian and endometrial
carcinomas by reverse transcription/polymerase chain reaction.
Gynecol Obstet Invest. 38:276–280. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lai CH, Hsueh S, Lin CY, Huang MY, You GB,
Chang HC and Pao CC: Human papillomavirus in benign and malignant
ovarian and endometrial tissues. Int J Gynecol Pathol. 11:210–215.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Beckmann AM, Sherman KJ, Saran L and Weiss
NS: Genital-type human papillomavirus infection is not associated
with surface epithelial ovarian carcinoma. Gynecol Oncol.
43:247–251. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
McLellan R, Buscema J, Guerrero E, Shah
KV, Woodruff JD and Currie JL: Investigation of ovarian neoplasia
of low malignant potential for human papillomavirus. Gynecol Oncol.
38:383–385. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Leake JF, Woodruff JD, Searle C, Daniel R,
Shah KV and Currie JL: Human papillomavirus and epithelial ovarian
neoplasia. Gynecol Oncol. 34:263–273. 1989. View Article : Google Scholar
|
|
68
|
Nikolakopoulou A, Mavridis D and Salanti
G: Demystifying fixed and random effects meta-analysis. BMJ Ment
Health. 17:53–57. 2014.
|
|
69
|
Schwarzer G: meta: An R package for
meta-analysis. R News. 7:40–45. 2007.
|
|
70
|
Higgins JP and Green S: Cochrane handbook
for systematic reviews of interventions. In: Cochrane Handbook for
Systematic Reviews of Interventions. Wiley; 2019
|
|
71
|
Paule RC and Mandel J: Consensus values
and weighting factors. J Res Natl Bur Stand (1977). 87:377–385.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Balduzzi S, Rücker G and Schwarzer G: How
to perform a meta-analysis with R: A practical tutorial. Evid Based
Ment Health. 22:153–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Sterne JA, Sutton AJ, Ioannidis JP, Terrin
N, Jones DR, Lau J, Carpenter J, Rücker G, Harbord RM, Schmid CH,
et al: Recommendations for examining and interpreting funnel plot
asymmetry in meta-analyses of randomised controlled trials. BMJ.
343:d40022011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Begg CB and Mazumdar M: Operating
characteristics of a rank correlation test for publication bias.
Biometrics. 50:1088–1101. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Peters JL, Sutton AJ, Jones DR, Abrams KR
and Rushton L: Comparison of two methods to detect publication bias
in meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Viechtbauer W: Conducting meta-analyses in
R with the metafor package. J Stat Soft. 36:1–48. 2010. View Article : Google Scholar
|
|
77
|
R Core Team, . R: A language and
environment for statistical computing. R Foundation for Statistical
Computing; Vienna: 2023
|
|
78
|
Schwarzer G, Carpenter JR and Rücker G:
metasens: Statistical methods for sensitivity analysis in
meta-analysis. R package version 1.5–2. https://CRAN.R-project.org/package=metasens
|
|
79
|
Halec G, Alemany L, Quiros B, Clavero O,
Höfler D, Alejo M, Quint W, Pawlita M, Bosch FX and de Sanjose S:
Biological relevance of human papillomaviruses in vulvar cancer.
Mod Pathol. 30:549–562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Lechner M, Liu J, Masterson L and Fenton
TR: HPV-associated oropharyngeal cancer: Epidemiology, molecular
biology and clinical management. Nat Rev Clin Oncol. 19:306–327.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Bjørge T, Engeland A, Luostarinen T, Mork
J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E,
Thoresen SO and Dillner J: Human papillomavirus infection as a risk
factor for anal and perianal skin cancer in a prospective study. Br
J Cancer. 87:61–64. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Chan PJ, Seraj IM, Kalugdan TH and King A:
Evidence for ease of transmission of human papillomavirus DNA from
sperm to cells of the uterus and embryo. J Assist Reprod Genet.
13:516–519. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Dyson N, Howley PM, Münger K and Harlow E:
The human papilloma virus-16 E7 oncoprotein is able to bind to the
retinoblastoma gene product. Science. 243:934–937. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Hashiguchi Y, Tsuda H, Yamamoto K, Inoue
T, Ishiko O and Ogita S: Combined analysis of p53 and RB pathways
in epithelial ovarian cancer. Hum Pathol. 32:988–996. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Bruni L, Albero G, Serrano B, Mena M,
Collado J, Gómez D, Muñoz J, Bosch F and de Sanjosé S: ICO/IARC
Information Centre on HPV and Cancer (HPV Information Centre).
Human papillomavirus and related diseases in the world. Summary
Report 10 March 2023. https://hpvcentre.net/statistics/reports/XWX.pdfOctober
8–2023
|
